BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

17 reasons why BPAX should open above a $1

I have taken the time to provide the links to the products and pipelines of the below noted companies along with their market cap (in $ million).

Look at this.
Biosante Pipeline $70.69 m

Biosnate \cancer \vaccine pipeline


Now look at these.

Myrexis Development Pipeline $72.46 m

Acadia Pharma pipeline $73.92 m

Nabi Pipeline $74.62 m

Cytokinetics Pipeline $ 75.17 m

Threshold Pharma $ 75.17 m

Tranzine pipeline $79.57 m

Peregrine pipeline $ 80.19 m

Aastrom Pipeline $83.04 mi

Cel Sci pipeline $93.08 m

Albany Molecular Research pipeline $ 94.06

INSMED Pipeline $94.37 m

Orexigen pipeline $100.98 m

Apricus Bioscience Pipeline $108.80 m

Gentium Pipeline $108.83 m

Zalicus pipeline $109.16 m

Repligen pipeline $109.19 m

Trancept pipeline $109.66 m

You will notice that only one or two companies have ever taken an FDA product to market and their pipelines don't even belong in the same post.

Conclusion BPAX belongs well over $1 per share at opening. Folks it doesn't get any simpler then this.